Correlation Between Propanc Biopharma and Vir Biotechnology

Can any of the company-specific risk be diversified away by investing in both Propanc Biopharma and Vir Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Propanc Biopharma and Vir Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Propanc Biopharma and Vir Biotechnology, you can compare the effects of market volatilities on Propanc Biopharma and Vir Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Propanc Biopharma with a short position of Vir Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Propanc Biopharma and Vir Biotechnology.

Diversification Opportunities for Propanc Biopharma and Vir Biotechnology

0.32

Correlation Coefficient

Propanc Biopharma  Vir Biotechnology

Weak diversification

The 3 months correlation between Propanc and Vir is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Propanc Biopharma and Vir Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vir Biotechnology and Propanc Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Propanc Biopharma are associated (or correlated) with Vir Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vir Biotechnology has no effect on the direction of Propanc Biopharma i.e., Propanc Biopharma and Vir Biotechnology go up and down completely randomly.

Pair Corralation between Propanc Biopharma and Vir Biotechnology

Given the investment horizon of 90 days Propanc Biopharma is expected to generate 4.38 times more return on investment than Vir Biotechnology. However, Propanc Biopharma is 4.38 times more volatile than Vir Biotechnology. It trades about 0.01 of its potential returns per unit of risk. Vir Biotechnology is currently generating about -0.02 per unit of risk. If you would invest  0.13  in Propanc Biopharma on September 27, 2024 and sell it today you would lose (0.11) from holding Propanc Biopharma or give up 84.62% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Propanc Biopharma  vs.  Vir Biotechnology

Propanc Biopharma

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Propanc Biopharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Propanc Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Vir Biotechnology

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Vir Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable forward indicators, Vir Biotechnology is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Propanc Biopharma and Vir Biotechnology

The main advantage of trading using opposite Propanc Biopharma and Vir Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Propanc Biopharma position performs unexpectedly, Vir Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vir Biotechnology will offset losses from the drop in Vir Biotechnology's long position.

The idea behind Propanc Biopharma and Vir Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.